Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 7460731551

About The Journal Open Access

Journal of Cancer Immunology & Therapy

The journal welcomes submissions from all related fields to the Cancer Immunology & Therapy which utilises the immune system as a treatment for cancer. Cancer immunology is an interdisciplinary branch of biology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well-known application is cancer immunotherapy.

Aims and Scope

Journal of Cancer Immunology & Therapy is a peer-reviewed, open access journal that reflects articles on all types of tumor immunology. The journal serves as a forum for new concepts and advances in basic Cancer Discovery, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Cancer Surgery, Advances in Cancer Prevention, Breast Cancer, Cancer Biology, Cancer Treatment, Cancer Management and Research, Integrative Cancer Therapies, Clinical cancer immunology and therapy.

Journal of Cancer Immunology & Therapy organize a new platform for the researchers, scientists, scholars, students in this field to publish their research work & update the latest research information to the scientific community. Chief criteria for acceptance are scientific novelty and quality, originality, clarity, and conciseness with early online publication, regular podcasts and an immense archive collection.

You can submit your manuscript at https://www.scholarscentral.org/submissions/cancer-immunology-therapy.html as an email attachment to the e-mail id at [email protected]

h-index

Articles published in Journal of Cancer Immunology & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Cancer Immunology & Therapy has got h-index 2 , which means every article in Journal of Cancer Immunology & Therapy has got 2 average citations.

Please submit your manuscript to
[email protected]

Just Published Articles View More

Opinion Article June 29, 2022

P.1-2

J Cancer Immunol Ther: 5(3): 1-2

New researches in treating patients with leukemia.

Ann Landers*

DOI:

Short Communication June 29, 2022

P.1-2

J Cancer Immunol Ther: 5(3): 1-2

Importance of natural killer (NK) cells in therapy of cancer.

Richard Bachman*

DOI:

Rapid Communication June 29, 2022

P.1-2

J Cancer Immunol Ther: 5(3): 1-2

Use of biomarkers, therapeutic treatment for hepatocellular carcinoma.

Mark Twain*

DOI:

Mini Review June 29, 2022

P.1-2

J Cancer Immunol Ther: 5(3): 1-2

Epidemiological aspects in controlling of cancer.

Alan Gould*

DOI:

Mini Review June 29, 2022

P.1-2

J Cancer Immunol Ther: 5(3): 1-2

Use of immunotherapies in the treatment of cancer patients.

Calthorpe Strange

DOI:

Commentary May 17, 2022

P.1-2

J Cancer Immunol Ther: 5(2): 1-2

The development and functioning of B- cell lymphocytes in a human body.

Erle Douglas*

DOI:

Relevant Topics

Get the App